Narrow search
Showing 1 - 10 of 36,279
Cover Image
Health-Related Quality-of-Life Measurement in Hypertension: A Review of Randomised Controlled Drug Trials
Cote, Isabelle; Gregoire, Jean-Pierre; Moisan, Jocelyne - In: PharmacoEconomics 18 (2000) 5, pp. 435-450
In hypertension, tolerability of drug treatment is important because individuals may see the use of antihypertensive …
Persistent link: https://www.econbiz.de/10005449301
Cover Image
Pharmacoeconomics of Hypertension Management: The Place of Combination Therapy
Ambrosioni, Ettore - In: PharmacoEconomics 19 (2001) 4, pp. 337-347
Pharmacological treatment of hypertension has been shown to reduce the risk of stroke, coronary events, heart failure …
Persistent link: https://www.econbiz.de/10005449057
Cover Image
Measuring and Managing Health Outcomes and Quality of Care in End-Stage Renal Disease
Kinchen, Kraig S.; Powe, Neil R. - In: Disease Management and Health Outcomes 9 (2001) 9, pp. 483-493
Health outcomes measurement has become increasingly important in the care of patients with end-stage renal disease (ESRD). Interest has been stimulated by the relatively poor outcomes of patients with ESRD, variations in the process of care, the high costs of ESRD care, and the development of...
Persistent link: https://www.econbiz.de/10005448875
Cover Image
Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction: Economic Evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from th...
Schadlich, Peter K.; Huppertz, Eduard; Brecht, Josef Georg - In: PharmacoEconomics 14 (1998) 6, pp. 653-669
Objective: Data from the Acute Infarction Ramipril Efficacy (AIRE) study were used in a cost-effectiveness analysis to … determine the incremental cost per life-year gained (LYG) when the ACE inhibitor ramipril was added to conventional treatment in … patients with heart failure after acute myocardial infarction. In the AIRE trial, the addition of ramipril significantly …
Persistent link: https://www.econbiz.de/10005449120
Cover Image
Outcomes Associated with a Disease Management Program for End-Stage Renal Disease
Nissenson, Allen R. - In: Disease Management and Health Outcomes 10 (2002) 2, pp. 93-100
Disease-state management is gaining in use for the management of chronically ill individuals including those with diabetes mellitus, congestive heart failure, asthma, and some forms of cancer. Recently, disease management (DM) has been applied to patients with chronic kidney disease (CKD), a...
Persistent link: https://www.econbiz.de/10005404727
Cover Image
Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies
Levy, Emile; Levy, Pierre - In: PharmacoEconomics 20 (2002) 14, pp. 963-977
Over the last two decades the incidence of congestive heart failure (CHF) has increased with aging of the population and in spite of the decline in age-adjusted mortality rates due to coronary heart disease. Its management has seen substantial progress, embodied in the introduction of ACE...
Persistent link: https://www.econbiz.de/10005448970
Cover Image
Augmenting Reference Pricing of Pharmaceuticals in New Zealand with Strategic Cross-Product Agreements
Woodfield, Alan - In: PharmacoEconomics 19 (2001) 4, pp. 365-377
Reference pricing pharmaceuticals in New Zealand involves reimbursing drugs at the lowest price ruling in a given therapeutic subgroup, and has been argued to promote competition leading to equalised prices among similar drugs. Disappointment at the inability to contain public drug expenditures...
Persistent link: https://www.econbiz.de/10005449071
Cover Image
ACE Inhibitors after Myocardial Infarction: Clinical and Economic Considerations
Davie, Andrew P. - In: PharmacoEconomics 17 (2000) 3, pp. 237-243
Economic analysis has been extensively used to guide the use of ACE inhibitors in chronic heart failure. More recently, it has been used to guide the use of ACE inhibitors after myocardial infarction. The results of major clinical trials leave us in no doubt that ACE inhibitors are useful in the...
Persistent link: https://www.econbiz.de/10005449244
Cover Image
The Role of Different Types of Health Insurance on Access and Utilization of Antihypertensive Drugs: An Empirical Study in a US Hypertensive Population
Huttin, Christine - In: Disease Management and Health Outcomes 10 (2002) 7, pp. 419-430
in this program. Patients and Participants: A sample of 1844 individuals diagnosed with hypertension was extracted from … on physician prescribing decisions for patients with hypertension, especially for patients covered by Medicare alone …
Persistent link: https://www.econbiz.de/10005448796
Cover Image
An Empirical Model for the Development of Disease Management Programs in General Practice: A Case Study Using Hypertension
Turnbull, Deborah A.; Mensforth, Helen; Beilby, Justin J.; … - In: Disease Management and Health Outcomes 10 (2002) 11, pp. 723-729
disease management programs in general practice. The model was developed applying the example of hypertension. Methods: Using … consumers. Results: The outcome of the research was a testable definition of disease management for hypertension, and the … Australian Disease Management Approach to Hypertension in General Practice (ADAGE) for patients at low to high risk of major …
Persistent link: https://www.econbiz.de/10005448833